ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling

Resistance of hepatocellular carcinoma (HCC) to existing chemotherapeutic agents largely contributes to the poor prognosis of patients, and discovery of novel anti-HCC drug is in an urgent need. Herein we report ψ-Bufarenogin, a novel active compound that we isolated from the extract of toad skin, e...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jin, Wen, Wen, Xiang, Daimin, Yin, Peipei, Liu, Yanfang, Liu, Chang, He, Guoping, Cheng, Zhuo, Yin, Jianpeng, Sheng, Chunquan, Zhang, Wen, Nan, Fajun, Ye, Wencai, Zhang, Xiuli, Wang, Hongyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484481/
https://www.ncbi.nlm.nih.gov/pubmed/25890498

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484481/
https://www.ncbi.nlm.nih.gov/pubmed/25890498

Ejemplares similares